1. Home
  2. GKOS vs RMTI Comparison

GKOS vs RMTI Comparison

Compare GKOS & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$110.62

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

HOLD

Current Price

$0.88

Market Cap

35.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
RMTI
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
35.1M
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
GKOS
RMTI
Price
$110.62
$0.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
1
Target Price
$126.38
$2.50
AVG Volume (30 Days)
670.7K
243.1K
Earning Date
02-19-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$469,820,000.00
$75,577,000.00
Revenue This Year
$31.15
N/A
Revenue Next Year
$24.15
$8.12
P/E Ratio
N/A
N/A
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$0.78
52 Week High
$163.71
$2.41

Technical Indicators

Market Signals
Indicator
GKOS
RMTI
Relative Strength Index (RSI) 54.91 48.05
Support Level $115.07 $0.80
Resistance Level $117.94 $0.89
Average True Range (ATR) 2.72 0.06
MACD -1.03 0.00
Stochastic Oscillator 25.00 49.20

Price Performance

Historical Comparison
GKOS
RMTI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Share on Social Networks: